How to manage truncal acne: A treatment algorithm

Affiliations

¹ Private Practice, Paris, France.
² Private Practice, Tours, France.
³ Department of Dermatology, Allergology and Photobiology, CHU A Michallon, Grenoble, France.
⁴ Private Practice, Talence, France.
⁵ INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, CHU Nantes-Hôtel-Dieu, Nantes, France.

Nicole Auffret et al. J Eur Acad Dermatol Venereol. 2023.

. 2023 Apr 5.

doi: 10.1111/jdv.19106. Online ahead of print.

¹ Private Practice, Paris, France.
² Private Practice, Tours, France.
³ Department of Dermatology, Allergology and Photobiology, CHU A Michallon, Grenoble, France.
⁴ Private Practice, Talence, France.
⁵ INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, CHU Nantes-Hôtel-Dieu, Nantes, France.

No abstract available

References

1. Nast A, Dreno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(Suppl 1):1-29.
1. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244-53.
1. Bell KA, Brumfiel CM, Haidari W, Boger L. Trifarotene for the treatment of facial and truncal acne. Ann Pharmacother. 2021;55(1):111-6.
1. Auffret N, Nguyen JM, Leccia MT, Claudel JP, Dréno B. TRASS: a global approach to assess the severity of truncal acne. J Eur Acad Dermatol Venereol. 2022;36(6):897-904.
1. Nast A, Dreno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, et al. European evidence-based (S3) guideline for the treatment of acne - update 2016 - short version. J Eur Acad Dermatol Venereol. 2016;30(8):1261-8.